An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment

An Overview of Drug Delivery Nanosystems for Sepsis-Related Liver Injury Treatment

Yi Lu,1,&ast; Yi Shi,1,&ast; Qian Wu,1 Xin Sun,1 Wei-Zhen Zhang,1 Xiao-Ling Xu,2 Wei Chen1 1ICU, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Shulan International Medical College, Zhejiang Shuren University, Hangzh...

Full description

Bibliographic Details
Main Authors:	Lu Y, Shi Y, Wu Q, Sun X, Zhang WZ, Xu XL, Chen W
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-02-01
Series:	International Journal of Nanomedicine
Subjects:	sepsis liver-injury drug delivery nanosystems hepatic inflammatory response hepatic oxidative stress bacterial translocation hepatic microcirculatory coagulation disorders.
Online Access:	https://www.dovepress.com/an-overview-of-drug-delivery-nanosystems-for-sepsis-related-liver-inju-peer-reviewed-fulltext-article-IJN

Similar Items

Applications of peptides in nanosystems for diagnosing and managing bacterial sepsis
by: Mohammed A. Gafar, et al.
Published: (2024-04-01)

Intestinal flora plays a role in the progression of hepatitis-cirrhosis-liver cancer
by: Shuyu Liu, et al.
Published: (2023-03-01)

Profiles of Clinical and Liver Function Test of Hepatitis B and C Patients with Liver Cirrhosis
by: Andreas Novaldi Watang, et al.
Published: (2023-01-01)

Thrombin Generation in Chronic Liver Diseases—A Pilot Study
by: Liliana Vecerzan, et al.
Published: (2021-05-01)

Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment
by: Margarida Ferreira-Silva, et al.
Published: (2022-01-01)

Gelatin-based anticancer drug delivery nanosystems: A mini review
by: Xianchao Jiang, et al.
Published: (2023-03-01)

The Current State of the Art in PARP Inhibitor-Based Delivery Nanosystems
by: Lisha Cai, et al.
Published: (2022-08-01)

Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications
by: Nakamwi Akombaetwa, et al.
Published: (2023-02-01)

Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study
by: Giuseppe Losurdo, et al.
Published: (2020-10-01)

Epidemiology and Risk Factors for Acute Viral Hepatitis in Bangladesh: An Overview
by: Mohammad Enamul Hoque Kayesh, et al.
Published: (2022-11-01)

Liver transplantation in a patient with hepatitis B, C and D coinfection associated with hepatocellular carcinoma: a management strategy for a rare condition. Case report
by: Lucas Carvalho Dantas, et al.

Advanced Drug Delivery Micro- and Nanosystems for Cardiovascular Diseases
by: Siavash Iravani, et al.
Published: (2022-09-01)

Liver Abscess Complicated with an Inflammatory Myofibroblastic Tumor
by: Susana Rodrigues, et al.
Published: (2022-09-01)

Magnitude and genotype of hepatitis delta virus among chronic hepatitis B carriers with a spectrum of liver diseases in Ethiopia
by: Yayehyirad Tassachew, et al.
Published: (2023-01-01)

Association between fatty liver index and blood coagulation markers: a population-based study
by: Maximilian Iglesias Morcillo, et al.
Published: (2023-06-01)

Viral Hepatitis in Patients with Inflammatory Bowel Disease
by: Seung Hwan Shin, et al.
Published: (2022-08-01)

Autoimmune Hepatitis Leading to Liver Cirrhosis: A Case Report
by: Moon Shrestha, et al.
Published: (2022-11-01)

Editorial: Pathophysiology and pharmacological treatments associated with liver failures
by: Chandana B. Herath, et al.
Published: (2024-04-01)

Principles of Nutritional Management in Patients with Liver Dysfunction—A Narrative Review
by: Essam Mohamed Elsebaie, et al.
Published: (2023-04-01)

Effects of Buprenorphine on Liver Enzymes in Patients without a History of Liver Disease
by: Maryam Rezaei, et al.
Published: (2022-07-01)

Defining a New Classification System for the Surgical Management of Neuroendocrine Tumor Liver Metastases
by: Kelly M. Mahuron, et al.
Published: (2023-03-01)

The role of platelets in sepsis: A review
by: Xinxin Xu, et al.
Published: (2024-01-01)

Comparative Analysis of the Efficacy of Different Regimens of 12 Months Rifaximin-Alfa Therapy in Patients with Liver Cirrhosis and Minimal Hepatic Encephalopathy
by: Igor G. Bakulin, et al.
Published: (2023-10-01)

A case report of successful liver retransplantation in patient with early hepatic artery thrombosis complicated by bile ducts necrosis and sepsis
by: D. A. Granov, et al.
Published: (2019-10-01)

Prevalence of Spontaneous Bacterial Peritonitis (SBP) in Hepatitis B (HBV), and Hepatitis C (HCV) Liver Cirrhosis: A Systematic Review and Meta-Analysis
by: Kizito Eneye Bello, et al.
Published: (2023-01-01)

Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications
by: Carlo Airola, et al.
Published: (2023-06-01)

The Role of ICG in Robot-Assisted Liver Resections
by: Anne-Sophie Mehdorn, et al.
Published: (2022-06-01)

Comparative hepatitis /
by: Weber, Olaf F., et al.
Published: (2008)

Synthesis and evaluation of nanosystem containing chondroitinase ABCI based on hydroxyapatite
by: Fatemeh Afraei, et al.
Published: (2024-02-01)

Hepatitis E
by: Ozzie Anis
Published: (2019-07-01)

A Comprehensive Review of the Diagnosis and Management of Acute Liver Failure
by: Nazli Begum Ozturk, et al.
Published: (2023-11-01)

Studying Hepatitis Virus-Host Interactions in Patient Liver Biopsies
by: Aleksei Suslov, et al.
Published: (2022-11-01)

Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases
by: Makoto Iijima, et al.
Published: (2021-01-01)

Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
by: Saffiya Habib, et al.
Published: (2021-02-01)

The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B
by: In Ku Yo, et al.
Published: (2015-03-01)

Risk factors for fractures following liver transplantation: a population-based cohort study
by: Jei-Wen Chang, et al.
Published: (2023-12-01)

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B—A Retrospective Cohort Study
by: Wang QX, et al.
Published: (2022-08-01)

Engineered drug delivery nanosystems for tumor microenvironment normalization therapy
by: Yang, Beining, et al.
Published: (2023)

An Overview of the Action Plans of the Islamic Republic of Iran toward Elimination of Viral Hepatitis B and C
by: Amjad Mohamadi Bolbanabad, et al.
Published: (2023-05-01)

Gut microbe and hepatic macrophage polarization in non-alcoholic fatty liver disease
by: Yao Chen, et al.
Published: (2023-12-01)